BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32156177)

  • 1. Durable response to combination radiotherapy and immunotherapy in EP-resistant lung large-cell neuroendocrine carcinoma with
    Qin Y; Yu M; Zhou L; Jiang L; Huang M
    Immunotherapy; 2020 Mar; 12(4):223-227. PubMed ID: 32156177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete tumor response of a locally advanced lung large-cell neuroendocrine carcinoma after palliative thoracic radiotherapy and immunotherapy with nivolumab.
    Mauclet C; Duplaquet F; Pirard L; Rondelet B; Dupont M; Pop-Stanciu C; Vander Borght T; Remmelink M; D'Haene N; Lambin S; Wanet M; Remouchamps V; Ocak S
    Lung Cancer; 2019 Feb; 128():53-56. PubMed ID: 30642453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term survivor of pulmonary combined large cell neuroendocrine carcinoma treated with nivolumab.
    Oda R; Okuda K; Yamashita Y; Sakane T; Tatematsu T; Yokota K; Endo K; Nakanishi R
    Thorac Cancer; 2020 Jul; 11(7):2036-2039. PubMed ID: 32379390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large Cell Neuroendocrine Carcinoma of the Lung: Clinico-Pathologic Features, Treatment, and Outcomes.
    Naidoo J; Santos-Zabala ML; Iyriboz T; Woo KM; Sima CS; Fiore JJ; Kris MG; Riely GJ; Lito P; Iqbal A; Veach S; Smith-Marrone S; Sarkaria IS; Krug LM; Rudin CM; Travis WD; Rekhtman N; Pietanza MC
    Clin Lung Cancer; 2016 Sep; 17(5):e121-e129. PubMed ID: 26898325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile.
    Hermans BCM; Derks JL; Thunnissen E; van Suylen RJ; den Bakker MA; Groen HJM; Smit EF; Damhuis RA; van den Broek EC; ; Ruland A; Speel EJM; Dingemans AMC
    Lung Cancer; 2019 Dec; 138():102-108. PubMed ID: 31678831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC).
    Hermans BCM; Derks JL; Thunnissen E; van Suylen RJ; den Bakker MA; Groen HJM; Smit EF; Damhuis RA; van den Broek EC; Stallinga CM; Roemen GM; Speel EJM; Dingemans AC;
    Lung Cancer; 2019 Apr; 130():179-186. PubMed ID: 30885341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymoquinone Plus Immunotherapy in Extra-Pulmonary Neuroendocrine Carcinoma: Case Series for a Novel Combination.
    Mohamed A; Azmi AS; Asa SL; Tirumani SH; Mahipal A; Cjakrabarti S; Bajor D; Selfridge JE; Kaseb AO
    Curr Oncol; 2022 Nov; 29(11):9018-9030. PubMed ID: 36421360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large cell neuroendocrine carcinoma of the lungs: case report and literature review.
    Han Y; Pang L; Huang J; Chen J
    Ann Palliat Med; 2020 Sep; 9(5):3705-3709. PubMed ID: 33065807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large cell/neuroendocrine carcinoma.
    Gollard R; Jhatakia S; Elliott M; Kosty M
    Lung Cancer; 2010 Jul; 69(1):13-8. PubMed ID: 20133008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Immunotherapy in Stage IV Large Cell Neuroendocrine Carcinoma of the Lung.
    Komiya T; Ravindra N; Powell E
    Asian Pac J Cancer Prev; 2021 Feb; 22(2):365-370. PubMed ID: 33639649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-depth molecular analysis of combined and co-primary pulmonary large cell neuroendocrine carcinoma and adenocarcinoma.
    Hermans BCM; Derks JL; Hillen LM; van der Baan I; van den Broek EC; von der Thüsen JH; van Suylen RJ; Atmodimedjo PN; den Toom TD; Coumans-Stallinga C; Timens W; Dinjens WNM; Dubbink HJ; Speel EM; Dingemans AC;
    Int J Cancer; 2022 Mar; 150(5):802-815. PubMed ID: 34674268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features of unresectable high-grade lung neuroendocrine carcinoma diagnosed using biopsy specimens.
    Shimada Y; Niho S; Ishii G; Hishida T; Yoshida J; Nishimura M; Yoh K; Goto K; Ohmatsu H; Ohe Y; Nagai K
    Lung Cancer; 2012 Mar; 75(3):368-73. PubMed ID: 21920624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant Therapy for Patients With Early Large Cell Lung Neuroendocrine Cancer: A National Analysis.
    Raman V; Jawitz OK; Yang CJ; Tong BC; D'Amico TA; Berry MF; Harpole DH
    Ann Thorac Surg; 2019 Aug; 108(2):377-383. PubMed ID: 31004586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical Analysis of 22 Cases of Pulmonary Large Cell Neuroendocrine Cancer].
    Qian Z; Hu Y; Zheng H; Dong Y; Wang Q; Li B
    Zhongguo Fei Ai Za Zhi; 2016 Feb; 19(2):82-7. PubMed ID: 26903161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct clinicopathologic features, genomic characteristics and survival of central and peripheral pulmonary large cell neuroendocrine carcinoma: From different origin cells?
    Zhou F; Hou L; Ding T; Song Q; Chen X; Su C; Li W; Gao G; Ren S; Wu F; Fan J; Wu C; Zhang J; Zhou C
    Lung Cancer; 2018 Feb; 116():30-37. PubMed ID: 29413048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome and prognostic factors of multimodal therapy for pulmonary large-cell neuroendocrine carcinomas.
    Rieber J; Schmitt J; Warth A; Muley T; Kappes J; Eichhorn F; Hoffmann H; Heussel CP; Welzel T; Debus J; Thomas M; Steins M; Rieken S
    Eur J Med Res; 2015 Aug; 20(1):64. PubMed ID: 26272455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated pathological analysis to develop a Gal-9 based immune survival stratification to predict the outcome of lung large cell neuroendocrine carcinoma and its usefulness in immunotherapy.
    Che Y; Luo Z; Cao Y; Wang J; Xue Q; Sun N; He J
    Int J Biol Sci; 2022; 18(15):5913-5927. PubMed ID: 36263183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor prognosis of ovarian cancer with large cell neuroendocrine carcinoma: case report and review of published works.
    Asada K; Kawana K; Teshima S; Saito A; Kawabata M; Fujii T
    J Obstet Gynaecol Res; 2014 Mar; 40(3):869-72. PubMed ID: 24738132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary large cell neuroendocrine carcinoma: its place in the spectrum of pulmonary carcinoma.
    Iyoda A; Hiroshima K; Nakatani Y; Fujisawa T
    Ann Thorac Surg; 2007 Aug; 84(2):702-7. PubMed ID: 17643676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathologic diagnosis of large cell neuroendocrine carcinoma of the lung in an axillary lymph node: a case report with immunohistochemical and molecular genetic studies.
    Terada T
    Int J Clin Exp Pathol; 2013; 6(6):1177-9. PubMed ID: 23696939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.